Eghtedari Masoomeh, Kamalzadeh Mahmood, Yasemi Masoud, Movahedan Hossein, Ashraf Mohammad Javad
Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Associate Professor, Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
J Ophthalmol. 2020 Nov 4;2020:2546923. doi: 10.1155/2020/2546923. eCollection 2020.
Corneal regrafts sometimes needed to restore the transparency after graft failure. The aim of the study is five years epidemiologic and histopathological evaluation of corneal regrafts.
In this cross-sectional study, all corneal regrafts during 5 years (2012-2016) were assessed in the Khalili Ophthalmology Center at Shiraz city. Demographic data including age, area of residence, primary disease, type of graft, cause of regraft, interval between primary and subsequent grafts (IPSG), associated eye diseases or surgeries, and systemic diseases were recorded. Also, microscopic findings of corneas were reviewed.
Among a total of 1190 corneal grafts, 76 of them (6.38%) were regrafts. The most common type of grafting was penetrating keratoplasty (PK). The shortest IPSG was observed in fungal keratitis. Main causes of graft failure were endothelial dysfunction, infection, immunologic rejection, technical problems, and recurrence of primary disease, respectively. The most common histopathological finding in failed grafts was severe endothelial cell loss (89.8%). Also, more than half and one-third of cases had Descemet membrane changes and stromal ingrowth, respectively.
Endothelial cell loss was the major cause of failure in our study. Also, recurrence rate in infective cases, especially fungal keratitis, was very high. Considerable presence of histopathological changes such as doubling of Descemet membrane and retrocorneal fibrous ingrowth need further investigations. Perhaps, modification in techniques of corneal grafting and assessment of donor tissue and recipient bed along with any need for longer medical treatment are the basis for future studies in order to increase graft survival.
角膜再次移植有时是为了在移植失败后恢复透明度。本研究的目的是对角膜再次移植进行为期五年的流行病学和组织病理学评估。
在这项横断面研究中,对设拉子市哈利利眼科中心5年(2012 - 2016年)期间的所有角膜再次移植进行了评估。记录了人口统计学数据,包括年龄、居住地区、原发性疾病、移植类型、再次移植的原因、初次移植与后续移植之间的间隔时间(IPSG)、相关的眼部疾病或手术以及全身性疾病。此外,还对角膜的显微镜检查结果进行了回顾。
在总共1190例角膜移植中,有76例(6.38%)为再次移植。最常见的移植类型是穿透性角膜移植术(PK)。在真菌性角膜炎中观察到最短的IPSG。移植失败的主要原因分别是内皮功能障碍、感染、免疫排斥、技术问题和原发性疾病复发。失败移植中最常见的组织病理学发现是严重的内皮细胞丢失(89.8%)。此外,分别有超过一半和三分之一的病例出现了Descemet膜改变和基质内生。
在我们的研究中,内皮细胞丢失是失败的主要原因。此外,感染性病例,尤其是真菌性角膜炎的复发率非常高。Descemet膜增厚和角膜后纤维内生等组织病理学改变的大量存在需要进一步研究。也许,改进角膜移植技术、评估供体组织和受体床以及延长任何必要的药物治疗时间是未来研究提高移植存活率的基础。